About Our Network – BOTOXCosmetic.com

	Materials for Network Members
	Administering BOTOX^® Cosmetic
	Clinical Information
	Professional Organizations
	Information for Consumers

Benefits of the BOTOX^® Cosmetic Physicians’ Network
As a member of the BOTOX^® Cosmetic Physicians’ Network, you’ll be part of a nationwide database that consumers can access—on the Web or by phone—to find physicians in their area.

We are confident that the BOTOX^® Cosmetic Physicians’ Network will help you reach patients who seek treatment with BOTOX^® Cosmetic for glabellar lines.

You’ll receive network support through a comprehensive kit, which includes:

Waiting room materials and brochures describing the benefits of BOTOX^® Cosmetic to encourage patients to ask about treatment
A patient education video that answers patients’ questions and enhances their treatment experience
An Award of Recognition for being a member of this elite network to foster patient confidence in choosing treatment with BOTOX^® Cosmetic
An "on-hold" telephone script that describes treatment with BOTOX^® Cosmetic to callers
Most frequently asked questions by BOTOX^® Cosmetic patients, with suggested answers. These materials are currently being updated to better serve you.

Read more about joining our Physicians’ Network

BOTOX^® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in patients 18 to 65 years of age.

Important Safety Information

BOTOX^® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation. There have been rare reports of adverse events involving the cardiovascular system. Serious and/or immediate hypersensitivity reactions have been reported rarely. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea.

The most common adverse events following injection include blepharoptosis and nausea. Localized pain, infection, inflammation, tenderness, swelling, erythema and/or bleeding/bruising may be associated with the injection. Patients with neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious adverse events.

Please see the additional safety information and full prescribing information.

Home | Prescribing Information | Privacy Policy | Contact Allergan | Site Map